Premises
Liquid Based Cytology represents today a profitable segment of the Cytology & Histology Market, accounting today over 20 bln USD globally and presenting a stable CAGR of 13,5%.
Cytofast is the most advanced monolayer LBC System available on the market, covering all the cytology reporting needs.
The business model, being the technology developed on a closed system, actually generate recurring revenues for years after installation. This means that once a customer base is acquired, it represents a stable value for the future.
Your time and efforts to provide us with the relevant information in the first step of the evaluation process is highly appreciated and every information provided will be treated as strictly confidential.
We always believe that our sales partners worldwide are our best asset, this is why we dedicate more energies in the preliminary evaluation phase.